Seminars in 2025
From Model to Market: Enhancing Phase 3 Design with MIDD
Jane Knöchel, InSilicoTrials, Sweden 2.9.2.2210:15 - 11:45
Model Informed Drug Development (MIDD) has revolutionized the way pharmaceutical companies approach Phase 3 clinical trials. By integrating predictive…
more ›Reducing the complexity of phase-field models for cell motility
Hidemasa Ishii, University of Tokyo 2.28.1.00109:15 - 10:45
Amoeboid cell motility involves the dynamics of cell shape, position, and intracellular patterns. In the phase-field approach, an artificial field…
more ›Bayesian model selection for partially observed second order Langevin dynamics
Yusuke Kato, University of Tokyo 2.28.1.00113:00 - 14:00
To describe and elucidate the mechanisms of cell motility, numerous SDE-based Langevin models have been proposed. However, the data-driven comparison…
more ›RIKEN’s activities to integrate data assimilation and AI/ML
Takemasa Miyoshi, RIKEN, Japan 2.28.0.10810:15 - 11:45
tba
more ›